Plasma dia-filtration for severe sepsis

Contributions to Nephrology

Volumn 166, Issue , 2010, Pages 142-149

  Eguchi, Yutaka ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; HEMODIAFILTRATION; HUMAN; METHODOLOGY; MULTICENTER STUDY; PLASMAPHERESIS; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; TECHNIQUE;

HEMODIAFILTRATION; HUMANS; METHODS; PLASMAPHERESIS; RETROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 84925946517     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314864     Document Type: Article

References (21)

1. Beale R, Reinhart K, Brunkhorst FM, Dobb G, Levy M, Martin G, Martin C, Ramsey G, Silva E, Vallent B, Vincent JL, Janes JM, Sarwat S, Williams MD, for the PROGRESS Advisory Board: Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an international sepsis registry. Infection 2009;37:222-232.
2. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K: Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003;31:2332-2338.
3. Hoste EAJ, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA: RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Critical Care 2006;10: R73.
4. Abosaif NY, Tolba YA, Heap M, Russell J, El Nahas AM: The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis 2005;46:1038-1048.
5. Williams R: Correction of disturbed pathophysiology of hepatic failure by albumin dialysis. Hepatobiliary Pancreat Dis Int 2008;7:19-24.
6. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT: Extracellular histones are major mediators of death in sepsis. Nature Med 2009;15:1318-1321.
7. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist
8. E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMGB-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
9. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Pallavicini FMB, Rottoli F, Giunta F, Ronco C: Early use of polymyxin B hemoperfusion in abdominal septic shock. JAMA 2009;301:2445-2452.
10. Matsuda K, Moriguchi T, Harii N, Goto J: Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure. Transfus Apher Sci 2009;40:49-53.
11. Lee D, Haase M, Haase-Fielitz A, Paizis K, Goehl H, Bellomo R: A pilot, randomized, double-blind, cross-over study of high cutoff versus high-flux dialysis membranes. Blood Purif 2009;28:365-372.
12. Mori T, Eguchi Y, Shimizu T, Endo Y, et al: A case of acute hepatic insufficiency treated with novel plasmapheresis plasma dia-filtration for bridge use until liver transplantation. Therapeutic Apheresis 2002;6:463-466.
13. Members of Society of Critical Care Med Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
14. Knaus WA, Draper EA, Wagner D P, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-829.
15. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sequential Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-710.
16. Bernard, GR, Vincent J-L, Laterre P-F, Larosa SP, Dhainut J-F, Lopez-Rodriguez A, Steingrub JS, Garber GE: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
17. Haase M, Bellomo R, Morger S, Baldwin I, Boyce N: High cut-off point membranes in septic acute renal failure: a systematic review. Int J Artif Organs 2007;30:1031-1041.
18. Stadlbanuer V, Krisper P, Aigner R, Haditsch B, Jung A, Lackner C, Stauber RE: Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-onchronic liver failure. Crit Care 2006;10: R169.
19. Llonen L, Koivusalo A-M, Hockerstedt K, Isoniemi H: Albumin dialysis has no clear effect on cytokine levels in patients with lifethreatening liver insufficiency. Transplant Proc 2006;38:3540-3543.
20. Llonen L, Koivusalo A-M, Repo H, Hockerstedt K, Isoniemi H: Cytokine profiles in acute liver failure treated with albumin dialysis. Artif Organs 2008;32:52-60.
21. Kikuchi H, Maruyama H, Omori S, Kazama JJ, Gejyo F: The Sequential Organ Failure Assessment Score as a useful predictor for estimating the prognosis of systemic inflammatory response syndrome patients being treated with extracorporeal blood purification. Ther Apher Dial 2003;7:456-460.